Scarica l'app Stockscreener
819.83
0.81%
-6.745
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché LLY Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Lilly Eli Co Borsa (LLY) Ultime notizie
Eli Lilly teams up with Indiana Latino Expo to enhance healthcare access - WISH-TV
Eli Lilly (LLY) Outpaces Stock Market Gains: What You Should Know - Yahoo Finance
Eli Lilly taps Goldman Sachs Asset Management for $25 billion OCIO deal - Pensions & Investments
Novo Nordisk’s Akero Therapeutics Buy Targets Eli Lilly’s Lead - MarketBeat
Lilly's oral GLP-1, orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, reconfirming its potential as a foundational treatment in type 2 diabetes - investor.lilly.com
Eli Lilly's Oral Weight Loss Drug Shows Superiority Over Two Approved Drugs - Benzinga
Eli Lilly Stock Price ForecastLLY Soars to $860 After Orforglipron Breakthrough - TradingNEWS
Eli Lilly: Outstanding Orforglipron Data Reinforces Value Proposition (NYSE:LLY) - Seeking Alpha
Lilly’s Oral GLP-1 Bests Another Big Pharma Bestseller in Phase III Diabetes Trial - BioSpace
Lilly's weight-loss pill shows better blood sugar control in late-stage trials - Reuters
Eli Lilly's orforglipron bests Farxiga, padding oral GLP-1 case with pair of phase 3 diabetes wins - Fierce Biotech
Eli Lilly (LLY) Advances Diabetes Treatment with Orforglipron Su - GuruFocus
Eli Lilly (LLY) Reports Promising Phase 3 Trial Results for Diab - GuruFocus
Eli Lilly oral obesity drug succeeds in diabetes trial (LLY) - Seeking Alpha
Lilly, battling skepticism, reinforces GLP-1 pill’s case with new study data - Yahoo Finance
Driven by the Engine of Innovation, Eli Lilly Leads a New Era in Healthcare - NAI500
FDA Approves Alzheimer’s Test Developed By Roche In Collaboration With Eli Lilly - Stocktwits
Major Shareholder Sells Millions in Eli Lilly Stock! - TipRanks
1 Reason Eli Lilly (LLY) Is One of the Best Healthcare Stocks You Can Buy Today - The Globe and Mail
Lilly Endowment sells $3.16 million in Eli Lilly shares - Investing.com
Eli Lilly eyes 2027 approval for new obesity drug: CEO - Nikkei Asia
Independence Bank of Kentucky Buys Another $3.1 Million Eli Lilly (NYSE: LLY) Shares - The Globe and Mail
Eli Lilly (LLY) Upgraded to 'Buy' Amid Promising Growth Catalysts - GuruFocus
Eli Lilly doubles down on Mounjaro despite rising competition in Brazil - Valor International
The Zacks Analyst Blog Highlights Apple, Eli Lilly and Visa - Nasdaq
Erste Group upgrades Eli Lilly stock rating to Buy after strong H1 results - Investing.com Canada
Top Stock Reports for Apple, Eli Lilly & Visa - Nasdaq
Eli Lilly and Company Strengthens Presence Among S&P 500 Companies - Kalkine Media
Eli Lilly: The Rally Has More Room To Run (Rating Upgrade) (NYSE:LLY) - Seeking Alpha
Lilly Wants To Know: What Does Chronic Illness Really Look Like? 10/13/2025 - MediaPost
Precision Trading with Eli Lilly And Company (LLY) Risk Zones - news.stocktradersdaily.com
Eli Lilly Omvoh Demonstrates Sustained Long-Term Benefits in Ulcerative Colitis Up to Four Years - Yahoo Finance
Eli Lilly (NYSE: LLY) Stock Price Prediction and Forecast 2025-2030 (Oct 2025) - 24/7 Wall St.
Eli Lilly Opens R&D Incubator for Life Sciences Startups - San Diego Business Journal
Aspen wins approval to market Lilly's Mounjaro for weight loss in South Africa - Reuters
Should Omvoh’s Clinical Success and Earnings Optimism Prompt Action from Eli Lilly (LLY) Investors? - simplywall.st
Should Omvoh’s Clinical Results and Innovation Drive a Rethink of Eli Lilly’s (LLY) Specialty Focus? - Yahoo Finance
The Goldman Sachs Group Issues Positive Forecast for Eli Lilly and Company (NYSE:LLY) Stock Price - MarketBeat
Insider Sales Surge: Block, Eli Lilly, Strategy, P&G, Dell - TipRanks
Eli Lilly and Company (NYSE:LLY) Stock Unloaded Rep. Val T. Hoyle - MarketBeat
Should Investors Buy Eli Lilly Stock? - The Globe and Mail
Meet this year’s Women in Biopharma; Peter Marks goes to Eli Lilly; Bob Langer startup launches; and more - Endpoints News
Gunderson Capital Management Inc. Increases Position in Eli Lilly and Company $LLY - MarketBeat
Seeking Safe Havens: Why Pfizer and Eli Lilly Are Top Market Picks Now? - NAI500
Eli Lilly (LLY): Revisiting Valuation After Recent Share Price Gains - simplywall.st
Lilly Endowment sells Eli Lilly shares worth $9.04 million - Investing.com
Eli Lilly and Co(LLY.US) 10% Shareholder Sells US$9.04 Million in Common Stock - 富途牛牛
Lilly Endowment unloads about $600 million in Eli Lilly stock during early October - Sherwood News
Eli Lilly’s New Study on Weight Reduction Drugs: A Potential Market Game-Changer? - TipRanks
Next medicine deal after Pfizer? Analysts, shares point to AstraZeneca, Eli Lilly - Reuters
Next Medicine Deal After Pfizer? Analysts, Shares Point to AstraZeneca, Eli Lilly - Money US News.com
WHO Arm Seeks Talks with Novo Nordisk, Eli Lilly on Expanding Access to Weight-loss Drugs - MarketScreener
Shape’s former CSO picks up tech role at Moderna; Lilly reels in Peter Marks - Endpoints News
2 Pharmaceutical Stocks That Look Like No-Brainer Buys Right Now - The Globe and Mail
Verde Servicos Internacionais S.A. Purchases New Position in Eli Lilly and Company $LLY - MarketBeat
Baxter Bros Inc. Lowers Stock Position in Eli Lilly and Company $LLY - MarketBeat
Major Shareholder Cashes Out Millions in Eli Lilly Stock! - TipRanks
LILLY ENDOWMENT INC Reduces Stake in Eli Lilly and Co - GuruFocus
Eli Lilly (LLY) Gains As Market Dips: What You Should Know - Yahoo Finance
Lilly Endowment sells Eli Lilly & Co (LLY) shares for $86.2m - Investing.com Canada
A Major Eli Lilly Shareholder Has Sold Stock Nearly Every Day in October. Here’s Who It Is. - MSN
0.58%
0.26%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):